PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224480
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224480
Cancer Biomarker Market with COVID-19 Impact Analysis, By Type, By Biomolecule, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Cancer Biomarker Market size was valued at USD 13,000.9 Million in 2022, expanding at a CAGR of 15.9% from 2023 to 2030.
A biological molecule found in the blood, tissues, or other physiological fluids that may be used to identify a disease or condition as well as normal or abnormal activity is known as a cancer biomarker. Cancer biomarkers are employed to identify changes in the tumor.
Cancer Biomarker Market- Market Dynamics
The market for cancer biomarkers is expanding due to the increasing prevalence of cancer. The cancer incidence rate, which is expressed as cancers per 100,000 individuals at risk, is the number of new cases of a certain location or type that occur in a given population over a given year. Cancer biomarkers are being widely used as a result of the rising frequency of the illness because they may be used to estimate disease risk, look for concealed primary tumors, distinguish benign from malignant symptoms, or distinguish one kind of malignancy from another. For instance, 1.8 million new instances of cancer were discovered in 2020, according to the American Cancer Society's report from 2021.
In addition, a crucial trend that is becoming increasingly popular in the cancer biomarker market is technological improvement. To maintain their position in the cancer biomarker industry, major market companies are creating cutting-edge technologies including artificial intelligence (AI), deep learning (DL), and machine learning (ML). These methods are being utilized to address issues related to the search for cancer biomarkers since processing huge amounts of molecular and imaging data is beyond the scope of traditional statistical tools and research. For instance, F. Hoffmann-La Roche AG, a Swiss pharmaceuticals and diagnostics company, launched uPath Ki-67 (30-9), uPath ER (SP1), and uPath PR (1E2), three new automated digital pathology algorithms that will be utilized as a biomarker for image analysis for breast cancer, in December 2021. This image analysis for breast cancer employs pathologist-trained deep learning algorithms to accelerate the detection of positive Ki-67, ER, and PR tumor cell nuclei.
Cancer Biomarker Market- Segmentation Analysis:
Based on the type, The market is divided into breast, prostate, colorectal, cervical, liver, and lung cancers. In 2022, breast cancer was the leading sector. Breast, lung, and prostate cancer will account for more than 45% of total revenue in 2022. The primary aspects leading to domination are increasing awareness of early testing and a bigger target demographic base. Lung cancer, on the other hand, is predicted to rise the quickest throughout the projection period. A growing number of diagnostic tests targeting EGFR and BRAF mutations, which function as an important biomarker for non-small cell lung cancer detection, are expected to drive category growth.
The market is further divided into genetic, epigenetic, metabolic, and proteomic biomarkers based on the biomolecule. Genetic biomarkers commanded a substantial market share due to their widespread use, high dependability rate, and ease of analysis. Over 85% of cancers have been shown to be identified using genetic and proteomic indicators. Besides, Epigenetics has received widespread recognition in the realm of cancer diagnoses. Many players are conducting extensive research to analyze major epigenetic modifications connected to cancer in order to further create biomarkers targeting medications. Increased collaboration between and pharmaceutical firms for the development of innovative medications targeting epigenetic biomarkers is expected to drive the growth of this segment.
Cancer Biomarker Market- Geographical Insights
North America led the regional segment, closely followed by Europe. The existence of prominent pharmaceutical corporations, developed R&D infrastructure relevant to the creation of novel diagnostic products, and rising demand for particular & early diagnoses are the primary reasons contributing to the aforementioned dominance. Besides, the Asia Pacific region is expected to see a profitable CAGR throughout the projection period due to rising cancer prevalence, a favorable environment for clinical trials, and increased government financing for drug development initiatives. Furthermore, the expanding emphasis of pharmaceutical firms on this region, along with rising knowledge of biomarker-based diagnostics, is one of the key growth factors.
Key features of the study:
This proposed research study on the Cancer Biomarker market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Cancer Biomarker market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Cancer Biomarker market
The impact of COVID-19 on the Cancer Biomarker market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Cancer Biomarker market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Cancer Biomarker market, we have also included a competitive landscape and key innovator analysis for the Cancer Biomarker market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Cancer Biomarker market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Cancer Biomarker market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER BIOMARKER MARKET KEY PLAYERS
Pfizer, Inc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Novartis AG
QIAGEN
F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Quest Diagnostics Incorporated.
Merck KGaA,
Hologic, Inc.
BD
GlaxoSmithKline plc
Illumina, Inc.
Thermo Fisher Scientific Inc.
DiagnoCure Inc.
Abbott
GLOBAL CANCER BIOMARKER MARKET, BY TYPE
Breast cancer
Prostate cancer
Colorectal cancer
Cervical cancer
Liver cancer
Lung cancer
Others
GLOBAL CANCER BIOMARKER MARKET, BY BIOMOLECULE
Genetic Biomarkers
Epigenetic Biomarkers
Metabolic Biomarkers
Proteomic Biomarkers
Others
GLOBAL CANCER BIOMARKER MARKET, BY APPLICATION
Drug discovery and Development
Diagnostics
Personalized medicine
Others
GLOBAL CANCER BIOMARKER MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Cancer Biomarker Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Cancer Biomarker Market Snippet by Type
- 2.1.2. Cancer Biomarker Market Snippet by Biomolecule
- 2.1.3. Cancer Biomarker Market Snippet by Application
- 2.1.4. Cancer Biomarker Market Snippet by Country
- 2.1.5. Cancer Biomarker Market Snippet by Region
- 2.2. Competitive Insights
3. Cancer Biomarker Key Market Trends
- 3.1. Cancer Biomarker Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Cancer Biomarker Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Cancer Biomarker Market Opportunities
- 3.4. Cancer Biomarker Market Future Trends
4. Cancer Biomarker Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Cancer Biomarker Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Cancer Biomarker Market Landscape
- 6.1. Cancer Biomarker Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Cancer Biomarker Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
- 7.1.2. Breast cancer
- 7.1.3. Prostate cancer
- 7.1.4. Colorectal cancer
- 7.1.5. Cervical cancer
- 7.1.6. Liver cancer
- 7.1.7. Lung cancer
- 7.1.8. Others
8. Cancer Biomarker Market - By Biomolecule
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Biomolecule, 2022 & 2030 (%)
- 8.1.2. Genetic Biomarkers
- 8.1.3. Epigenetic Biomarkers
- 8.1.4. Metabolic Biomarkers
- 8.1.5. Proteomic Biomarkers
- 8.1.6. Others
9. Cancer Biomarker Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 9.1.2. Drug discovery and Development
- 9.1.3. Diagnostics
- 9.1.4. Personalized medicine
- 9.1.5. Others
10. Cancer Biomarker Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Cancer Biomarker Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cancer Biomarker Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cancer Biomarker Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cancer Biomarker Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cancer Biomarker Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Biomolecule, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Cancer Biomarker Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd.
- 11.2.2. Thermo Fisher Scientific, Inc.
- 11.2.3. BIOCEPT, Inc.
- 11.2.4. Guardant Health, Inc.
- 11.2.5. QIAGEN
- 11.2.6. Illumina, Inc.
- 11.2.7. Angle plc
- 11.2.8. Oncimmune
- 11.2.9. Myriad Genetics, Inc.
- 11.2.10. Lucence health Inc.
- 11.2.11. EPIGENOMICS AG
- 11.2.12. FreenomeHoldings, Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Cancer Biomarker Market:Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Cancer Biomarker Market, by Type 2018-2030 (USD Million)
- TABLE Cancer Biomarker Market: Biomolecule Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Biomolecule
- TABLE Global Cancer Biomarker Market, by Biomolecule 2018-2030 (USD Million)
- TABLE Cancer Biomarker Market: Regional snapshot (2022)
- TABLE Cancer Biomarker Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Cancer Biomarker Market, by Application 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Cancer Biomarker Market, by Region 2018-2030 (USD Million)
- TABLE North America Cancer Biomarker Market, by Country, 2018-2030 (USD Million)
- TABLE North America Cancer Biomarker Market, by Type, 2018-2030 (USD Million)
- TABLE North America Cancer Biomarker Market, by Biomolecule, 2018-2030 (USD Million)
- TABLE North America Cancer Biomarker Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Cancer Biomarker Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Cancer Biomarker Market, by Type, 2018-2030 (USD Million)
- TABLE Europe Cancer Biomarker Market, by Biomolecule, 2018-2030 (USD Million)
- TABLE Europe Cancer Biomarker Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Cancer Biomarker Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Cancer Biomarker Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Cancer Biomarker Market, by Biomolecule, 2018-2030 (USD Million)
- TABLE Asia Pacific Cancer Biomarker Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Cancer Biomarker Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Cancer Biomarker Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Cancer Biomarker Market, by Biomolecule, 2018-2030 (USD Million)
- TABLE Latin America Cancer Biomarker Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Cancer Biomarker Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Cancer Biomarker Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Cancer Biomarker Market, by Biomolecule, 2018-2030 (USD Million)
- TABLE Middle East and Africa Cancer Biomarker Market, by Application, 2018-2030 (USD Million)
List of Figures
- FIGURE Cancer Biomarker Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Type segment market share analysis, 2022 & 2030
- FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Biomolecule segment market share analysis, 2022 & 2030
- FIGURE Biomolecule segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Application segment market share analysis, 2022 & 2030
- FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Cancer Biomarker Market share and leading players, 2022
- FIGURE Europe Cancer Biomarker Market share and leading players, 2022
- FIGURE Asia Pacific Cancer Biomarker Market share and leading players, 2022
- FIGURE Latin America Cancer Biomarker Market share and leading players, 2022
- FIGURE Middle East and Africa Cancer Biomarker Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Cancer Biomarker Market share analysis by country, 2022
- FIGURE Germany Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Cancer Biomarker Market share analysis by country, 2022
- FIGURE India Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Cancer Biomarker Market share analysis by country, 2022
- FIGURE Brazil Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Cancer Biomarker Market share analysis by country, 2022
- FIGURE Saudi Arabia Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Cancer Biomarker Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
